Percutaneous dilational tracheostomy--a clinical study evaluating two systems.
Percutaneous dilational tracheostomy (PDT), first described in the 1950s, has become a common bedside technique in the Intensive Care Unit (ICU). This study compares the early complications associated with the use of the Ciaglia PDT (Cook Critical Care, Bloomington, USA) technique, with the newly available Portex PDT technique (Portex Ltd., UK). The Ciaglia technique was adopted in this ICU in July 1994 and twenty-nine patients had a tracheostomy using this set until January 1995. Complications during the procedure were collected prospectively. When the Portex PDT set became available in January 1995, it was decided to assess the complication rate of this technique and compare them to the previously-collected data using the Ciaglia PDT set. Twenty-five patients have had a tracheostomy using the Portex PDT set. There has been no mortality associated with either PDT set. Bleeding requiring intervention occurred in two patients in the Ciaglia group and three patients in the Portex Group. All these patients had a bleeding diathesis. Loss of airway control occurred on one occasion in the Ciaglia group due to premature removal of the endotracheal tube. The first routine tracheostomy tube change at day 7 was complicated in four cases in the Ciaglia group. One infected stoma was noted in the Ciaglia group at day 7. Both techniques result in rapid, safe placement of a tracheostomy tube in critically ill patients in the ICU, obviating the need for surgical referral and transport to the operating room.
Van Heerden
P V
PV
Department of Intensive Care, Sir Charles Gairdner Hospital, Perth, Western Australia.
Webb
S A
SA
Power
B M
BM
Thompson
W R
WR
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004867:Equipment Design; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D008875:Middle Aged; D011785:Quality Assurance, Health Care; D014139:Tracheostomy / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods; D016896:Treatment Outcome